SYNKAYVITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synkayvite, and what generic alternatives are available?
Synkayvite is a drug marketed by Roche and is included in one NDA.
The generic ingredient in SYNKAYVITE is menadiol sodium diphosphate. Additional details are available on the menadiol sodium diphosphate profile page.
US Patents and Regulatory Information for SYNKAYVITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | SYNKAYVITE | menadiol sodium diphosphate | TABLET;ORAL | 003718-010 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
